Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 1289-1297, November 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gropper, L.
Right arrow Articles by Shimkin, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gropper, L.
Right arrow Articles by Shimkin, M. B.

Chemotherapeutic Response of 3-Methylcholanthrene-Induced Mammary Carcinoma in Wistar Rats to 51 Agents1

L. Gropper, M. Gruenstein and M. B. Shimkin2

Fifty-one chemical agents were tested for antitumor activity against mammary carcinoma induced by gastric instillations of 3-methylcholanthrene (NSC-21970) in female Wistar rats. Eight agents were active, that is, the tumor weight of treated animals at 42 days was less than 50% of the tumor weight in untreated controls (T/C < 0.5), without significant mortality or body weight loss in the treated animals. These agents were: colchicine (NSC-757); 4,4'-(1,2-diethylethylene)diphenyl hexestrol (NSC-9894); 17-hydroxy-6{alpha}-methylpregn-4-ene-3,20-dione acetate (NSC-26386); 5-bromo-2'-deoxyuridine (NSC-38297); 1-ß-D-arabinofuranosylcytosine, monohydrochloride (NSC-63878); 6ß-(dimethylamino)-3ß, 5-dihydroxy-5-pregnan-20-one (NSC-73862), 1-adamantine hydrochloride (NSC-83653); and 1,4-dimethyl-1,4-diphenyl-2-tetrazene (NSC-83799).

1 Supported by contract SA-43-ph-4344 from the Cancer Chemotherapy National Service Center, National Cancer Institute, National Institutes of Health, USPHS.

2 Fels Research Institute, Temple University School of Medicine, Philadelphia, Pennsylvania.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.